MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer.
Saved in:
| Title: | MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer. |
|---|---|
| Authors: | Li, Hui1,2 (AUTHOR), Hong, Lingzhi1,2 (AUTHOR), Rocha, Pedro3,4 (AUTHOR), Bach, Rafael3,4 (AUTHOR), Solis Soto, Luisa M.5 (AUTHOR), Rinsurongkawong, Waree1,6 (AUTHOR), Zhang, Bingnan1,7 (AUTHOR), Araujo, Haniel A.1,8 (AUTHOR), Elamin, Yasir Y.1,9 (AUTHOR), Altan, Mehmet1,10 (AUTHOR), Arrechedera, Claudio A.5,11 (AUTHOR), Zhou, Jianling1,6 (AUTHOR), Khan, Khaja B.2,5 (AUTHOR), Lu, Wei3,5 (AUTHOR), Young, Elliana4,7 (AUTHOR), Gay, Carl M.1,5 (AUTHOR), Cascone, Tina1,6 (AUTHOR), Byers, Lauren A.1,7 (AUTHOR), Skoulidis, Ferdinandos1,8 (AUTHOR), Blumenschein, George1,9 (AUTHOR) |
| Source: | Cancers. Dec2025, Vol. 17 Issue 23, p3801. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
